BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The B and T lymphocyte attenuator (BTLA) is an Ig super family member that binds to the herpes virus entry mediator (HVEM), a TNF receptor super family (TNFRSF) member. Engagement of BTLA by HVEM triggers inhibitory signals, although recent evidence indicates that BTLA also may act as an activating ligand for HVEM. In this study, we reveal a novel role for the BTLA-HVEM pathway in promoting the survival of activated CD8(+) T cells in the response to an oral microbial infection. Our data show that both BTLA- and HVEM-deficient mice infected with Listeria monocytogenes had significantly reduced numbers of primary effector and memory CD8(+) T cells, despite normal proliferation and expansion compared to controls. In addition, blockade of the BTLA-HVEM interaction early in the response led to significantly reduced numbers of antigen-specific CD8(+) T cells. HVEM expression on the CD8(+) T cells as well as BTLA expression on a cell type other than CD8(+) T lymphocytes, was required. Collectively, our data demonstrate that the function of the BTLA-HVEM pathway is not limited to inhibitory signaling in T lymphocytes, and instead, that BTLA can provide crucial, HVEM-dependent signals that promote survival of antigen activated CD8(+) T cell during bacterial infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, BTLA and herpesvirus entry mediator (HVEM) shares ligand on the same T lymphocytes (CD8+), and the same cell interaction happens, which suppresses T cell function [333].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883 · cited 5×
“Btla [3] and Hvem [9] mice were generously provided by Dr.”
BackgroundInfluentialCo-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1148 · Cited by 863
Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G.-L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80455-0 · Cited by 768
Self-citationSignals required for programming effector and memory development by CD8+ T cells
Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F., & Xiao, Z. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00382.x · Cited by 601
Herpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 581
Organ-Specific Regulation of the CD8 T Cell Response to Listeria monocytogenes Infection
Pope, C., Kim, S.-K., Marzo, A., Williams, K., Jiang, J., Shen, H., & Lefrançois, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3402 · Cited by 375
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Cai, G., Anumanthan, A., Brown, J. A., Greenfield, E. A., Zhu, B., & Freeman, G. J. (2008) · Nature Immunology · doi:10.1038/ni1554 · Cited by 345 · cited 1×
“More recently, CD160 was identified as a second Ig-domain containing molecule able to bind HVEM [8].”
BackgroundAranda, R., Sydora, B. C., McAllister, P. L., Binder, S. W., Yang, H. Y., Targan, S. R., & Kronenberg, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3464 · Cited by 312 · cited 1×
“performed as described previously [32].”
Self-citationScheu, S., Alferink, J., Pötzel, T., Barchet, W., Kalinke, U., & Pfeffer, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020215 · Cited by 260 · cited 1×
“Whereas in studies performed in vitro, the costimulatory function of LIGHT was required for optimal CD8 T cell activation, [25,26,27,28,29], LIGHT expression in mice was not required to control Listeria or”
BackgroundGonzalez, L. C., Loyet, K. M., Calemine-Fenaux, J., Chauhan, V., Wranik, B., Ouyang, W., & Eaton, D. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409071102 · Cited by 252 · cited 1×
“Interestingly, recent reports from Ertl and colleagues showed that the viral ligand HSV-1 gD, which competes for HVEM binding with BTLA [21,22], can enhance the adaptive immune response to viral antigens [23,24].”
Background
Cited by
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463
Self-citationTumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Kumar, P., Bhattacharya, P., & Prabhakar, B. S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.007 · Cited by 216
“BTLA is expressed on T-cells and APCs, whereas its ligand/counter-receptor HVEM is expressed on resting and activated T-cells[66].”
BackgroundThe function and dysfunction of memory CD 8+ T cells in tumor immunity
Reading, J. L., Gálvez‐Cancino, F., Swanton, C., Lladser, A., Peggs, K. S., & Quezada, S. A. (2018) · Immunological Reviews · doi:10.1111/imr.12657 · Cited by 180
Natural and Induced Tolerogenic Dendritic Cells
Iberg, C. A., & Hawiger, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901121 · Cited by 159
Roles of BTLA in Immunity and Immune Disorders
Ning, Z., Liu, K., & Xiong, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654960 · Cited by 157
“other cell types are necessary for the optimal survival of effector and memory T cells, suggesting that the BTLA/HVEM pathway enhances activated CD8 T cell survival in the process of Listeria infection (101).”
BackgroundThe TNF–TNFR Family of Co-signal Molecules
So, T., & Ishii, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_3 · Cited by 178
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
Gaikwad, S. R., Agrawal, M. Y., Kaushik, I., Ramachandran, S., & Srivastava, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.014 · Cited by 172
Jones, A., Bourque, J., Kuehm, L., Opejin, A., Teague, R. M., Gross, C., & Hawiger, D. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.008 · Cited by 154
“…cells, including CD8+ DCs, where it acts as a ligand for the herpesvirus entry mediator (HVEM), a tumor necro- sis factor receptor superfamily member expressed in resting and activated T cells (Cheung et al., 2005;Murphy andMurphy, 2010; Steinberg et al., 2013; Watanabe et al., 2003).”
Lu, T. T., & Browning, J. L. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00047 · Cited by 97
“, BTLA and CD160 and these proteins have contextspecific regulatory effects on T and NK cell function (20, 24, 25).”
BackgroundSordo‐Bahamonde, C., Lorenzo‐Herrero, S., Granda‐Díaz, R., Martínez‐Pérez, A., Aguilar-García, C., Rodrigo, J. P., Garcia-Pedrero, J. M., & Gonzalez, S. R. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01845-4 · Cited by 95
“Similarly, HVEM-mediated signaling has been linked to PI3K and AKT signaling pathway in T cells, although the exact mechanism needs to be fully elucidated [35–37].”
BackgroundImmunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells
Bourque, J., & Hawiger, D. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026790 · Cited by 82
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter
Ritthipichai, K., Haymaker, C., Martinez, M., Aschenbrenner, A., Yi, X., Zhang, M., Kale, C., Vence, L. M., Roszik, J., Hailemichael, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1217 · Cited by 80
“Interestingly, another study utilizing BTLA KO animals and LM-OVA infection concluded that HVEM expression on T cells transduces a survival signal through interaction with BTLA expressed on other cells in the host and that interactionwas required forCD8þT-cellmemory generation (31).”
BackgroundEvasion of Early Antiviral Responses by Herpes Simplex Viruses
Suazo, P. A., Ibañez, F. J., Retamal-Díaz, A. R., Paz-Fiblas, M. V., Bueno, S. M., Kalergis, A. M., & González, P. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/593757 · Cited by 73
“After gB-mediated attachment, gD binds to either of its receptors: nectin-1 (PVRL1; poliovirus receptor-related 1) expressed on the surface of most host cells or alternatively HVEM (Herpesvirus Entry Mediator, TNFRSF14), mainly expressed on immune cells [54, 55].”
BackgroundmiRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy
Zhang, M., Shi, Y., Zhang, Y., Wang, Y., Alotaibi, F., Qiu, L., Wang, H., Peng, S., Liu, Y., Li, Q., et al. (2020) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02507-w · Cited by 65
Check Point Inhibitors and Their Role in Immunosuppression in Sepsis
Wakeley, M. E., Gray, C. C., Monaghan, S. F., Heffernan, D. S., & Ayala, A. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.006 · Cited by 63
LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection
Seo, G., Shui, J., Takahashi, D., Song, C., Wang, Q., Kim, K., Mikulski, Z., Chandra, S., Giles, D. A., Zahner, S. P., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.008 · Cited by 55
“Furthermore, the generation of CD8 T cell mucosal memory to Listeria monocytogenes was dependent on HVEM (Steinberg et al., 2013).”
InfluentialSelf-citationHVEM network signaling in cancer
Šedý, J. R., & Ramezani-Rad, P. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.01.004 · Cited by 52
Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations
Tabana, Y., Moon, T. C., Siraki, A. G., Elahi, S., & Barakat, K. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1937123 · Cited by 50
“tases SHP1 and SHP2, which results in the inhibition of NFATbased signaling within the BTLA expressing cells, leading to attenuated antigen-driven T cell activation [120,121].”
BackgroundQuan, L., Lan, X., Meng, Y., Guo, X., Guo, Y., Zhao, L., Chen, X., & Liu, A. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.01.003 · Cited by 47
The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases
Wojciechowicz, K., Spodzieja, M., Lisowska, K. A., & Wardowska, A. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104532 · Cited by 49
Zhang, J., Lu, Y.-B., Wang, W., Liu, G.-B., Chen, C., Shen, L., Luo, H., Xu, H., Peng, Y., Luo, H., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00518 · Cited by 36
“HVEM and BTLA are involved together in a pathway involved in T cell activation (44), but HVEMwas not examined in the present study.”
BackgroundEpithelial HVEM maintains intraepithelial T cell survival and contributes to host protection
Seo, G., Takahashi, D., Wang, Q., Mikulski, Z., Chen, A., Chou, T.-F., Marcovecchio, P., McArdle, S., Sethi, A., Shui, J., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm6931 · Cited by 31
“Epithelial HVEM maintains IETs Considering the importance of HVEM for TCR+ CD8+ memory and resident memory T cell formation (34, 36), we tested for a T cell–intrinsic effect of HVEM expression.”
BackgroundSelf-citationAnnels, N. E., Simpson, G. R., Denyer, M., Arif, M., Coffey, M. C., Melcher, A. A., Harrington, K. J., Vile, R. G., & Pandha, H. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.09.010 · Cited by 32
“This function of BTLA as a trans-activating ligand delivering pro-survival signals through HVEM expressed on T cells has also been proposed for HVEM during infection with the intracellular bacteria Listeria monocytogenes.(54) Because we found similar kinetics of HVEM expression on T cells derived from reovirus-infecte…”
ResultThe BTLA-HVEM complex – The future of cancer immunotherapy
Wojciechowicz, K., Spodzieja, M., & Wardowska, A. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116231 · Cited by 32
HVEM is a TNF Receptor with Multiple Regulatory Roles in the Mucosal Immune System
Shui, J., & Kronenberg, M. (2014) · Immune Network · doi:10.4110/in.2014.14.2.67 · Cited by 26
“HVEM is an unusual TNF receptor because of its high expression levels in the gut epithelium, its capacity to bind ligands that are not members of the TNF super family, including immunoglobulin (Ig) superfamily members BTLA and CD160, and its bi-directional functionality, acting as a signaling receptor or as a ligand f…”
BackgroundInfluentialSelf-citationBourque, J., & Hawiger, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01163 · Cited by 26
Wang, W.-D., Gao, Y.-C., Lu, Y.-B., Zhang, J., Liu, G.-B., Kong, B., Xiang, W.-Y., Dai, Y.-C., Yu, S.-Y., Jia, Y., et al. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.09.015 · Cited by 24
BTLA + Dendritic Cells: The Regulatory T Cell Force Awakens
Simon, T., & Bromberg, J. S. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.030 · Cited by 22
“It is also important to note that the BTLA-HVEM pathway is not limited to inhibitory signaling in T lymphocytes, as it may enhance T cell effector function (Steinberg et al., 2013), and BTLA+CD8+ DCs deliver positive signals through HVEM expressed on T cells (Flynn et al., 2013).”
BackgroundNunoya, J.-I., Masuda, M., Ye, C., & Su, L. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.03.002 · Cited by 23
“to bacterial infection.(11) Additionally, tumor cells that express anti-HVEM single-chain antibody induce a potent proliferation and cytokine production of co-cultured T cells.”
BackgroundHVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity
Desai, P., Abboud, G., Stanfield, J., Thomas, P. G., Song, J. J., Ware, C. F., Croft, M., & Salek‐Ardakani, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700959 · Cited by 22
“some CD8 T cell responses (19, 20), but its role in T cell fate”
BackgroundResultSelf-citationThe Role of B and T Lymphocyte Attenuator in Respiratory System Diseases
Deng, Z. H., Zheng, Y., Cai, P., & Zheng, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635623 · Cited by 25
“This result suggests that BTLA-HVEM signaling pathway does not restrict to inhibitory signaling transmission, BTLA can promote the survival of antigen specific CD8 T cell to fight against bacterial infection through HVEM dependent signal pathway (26).”
BackgroundKannan, S., Kurupati, R. K., Doyle, S. A., Freeman, G. J., Schmader, K. E., & Ertl, H. C. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4597 · Cited by 23
“Other data showed that lack of BTLA reduced rather than augmented pathology in a colitis model [32] and promoted survival of antigen-specific CD8+ T cells induced by bacterial infection [33] again suggesting that BTLA may have disparate role in maintaining homeostasis of the immune system.”
BackgroundZhou, S., Gan‐Or, Z., Ambalavanan, A., Lai, D., Xie, P., Bourassa, C. V., Strong, S., Ross, J. P., Dionne‐Laporte, A., Spiegelman, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21603-7 · Cited by 22
BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis.
Zeng, J., Lin, D.-Z., Yi, L.-L., Liu, G.-B., Zhang, H., Wang, W.-D., Zhang, J., Wu, X.-J., Xiang, W.-Y., Kong, B., et al. (2014) · Europe PMC (PubMed Central) · Cited by 20
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
Davar, D., & Zarour, H. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_2 · Cited by 22
Brenu, E., Broadley, S., Nguyen, T. U., Johnston, S., Ramos, S. B., Staines, D., & Marshall‐Gradisnik, S. (2016) · Journal of Immunology Research · doi:10.1155/2016/9064529 · Cited by 18
HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage
Muscate, F., Stetter, N., Schramm, C., Wiesch, J. S. Z., Bosurgi, L., & Jacobs, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02611 · Cited by 15
Evasión de la respuesta inmune por virus herpes simplex
Retamal-Díaz, A. R., Suazo, P. A., Garrido, I., Kalergis, A. M., & González, P. A. (2015) · Revista chilena de infectología · doi:10.4067/s0716-10182015000200009 · Cited by 14
Accelerator or Brake: Immune Regulators in Malaria
Cai, C., Hu, Z., & Yu, X. H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.610121 · Cited by 14
Distinct Subcellular Compartments of Dendritic Cells Used for Cross-Presentation
Imai, J., Otani, M., & Sakai, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225606 · Cited by 11
“Without stimulation by innate immunity, cDC1s mediate naïve T cell tolerance by BTLA [34] and integrin αVβ8 with TGF-β [35,36]. cDC2 mainly trigger the TH2 response and show restricted CP ability as compared with cDC1s [24,37–39].”
Background(2015) · Europe PMC (PubMed Central) · Cited by 10
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection
del Rio, M., Nguyen, T. H., Tesson, L., Heslan, J., Gutiérrez‐Adán, A., Fernández‐González, R., Gutiérrez-Arroyo, J., Bühler, L. H., Pérez‐Simón, J. A., Anegón, I., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.08.006 · Cited by 9
BTLA agonist attenuates Th17-driven inflammation in a mouse model of steroid-resistant asthma
Quach, C., Li, X., Shafiei-Jahani, P., Li, M., Shen, S. M.-C., Helou, D. G., Hurrell, B. P., Soroosh, P., & Akbari, O. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1552394 · Cited by 7
“Additionally, the absence of BTLA-mediated inhibition could also prolong the survival of activated CD4 + T cells, potentially maintaining a chronic in fl ammatory state in the airways (79).”
Meldgaard, T. S., Blengio, F., Maffione, D., Sammicheli, C., Tavarini, S., Nuti, S., Kratzer, R., Medini, D., Siena, E., & Bertholet, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757151 · Cited by 8
Shan, Y., Zhang, B., Chen, L., Zhang, H., Jiang, C., You, Q., Li, Y., Han, H., & Zhu, J. (2022) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001336 · Cited by 4
Lv, M., Wu, W., Zhang, Y., & Zhu, M. (2015) · Scientific Reports · doi:10.1038/srep12954 · Cited by 3
Diethelm, P., Schmitz, I., Iten, I., Kisielow, J., Matsushita, M., & Köpf, M. (2022) · European Journal of Immunology · doi:10.1002/eji.202048569 · Cited by 2
Adegoke, A., Thangavelu, G., Chou, T.-F., Petersen, M., Kakugawa, K., May, J. F., Joannou, K., Wang, Q., Ellestad, K. K., Boon, L., et al. (2024) · Open Biology · doi:10.1098/rsob.240178 · Cited by 2
“HVEM signalling is also involved in survival of memory CD4 [60] and memory CD8 T cells [61,62].”
BackgroundSelf-citationÇETİN, Y., İlhan, F., Şen, D. E., & Çelik, S. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2019-0221 · Cited by 1
“According to a previous review, the engagement of HVEM with its endogenous ligand causes a strong immune response, but HVEM interactions with BTLA negatively manage T-cell responses [9].”
Background[Professor Rufin-Remi Schockaert (1875-1953)].
SONDERVORST, F. A. (1953) · PubMed
Takahashi, D., Wang, Q., Seo, G., Shui, J., Mikulski, Z., Marcovecchio, P., Takahashi, M., Surh, C. D., Cheroutre, H., & Kronenberg, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.30.317628
“HVEM is a multi-functional protein that previously was shown to influence inflammation and the response to acute infections in the intestinal mucosae (Breloer et al., 2015; Seo et al., 2018; Shui et al., 2012; Steinberg et al., 2013).”
BackgroundSelf-citationNunoya, J.-I., Teramura, E., Masuda, M., & Su, L. (2021) · Re GEN Open · doi:10.1089/regen.2021.0005
Kolls, J. K., & Matsunaga, Y. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733793319.793549716
Metadata
- Authors
- Steinberg, M. W., Huang, Y., Wang-Zhu, Y., Ware, C. F., Cheroutre, H., & Kronenberg, M.
- Affiliations
- La Jolla Institute for Immunology (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Kronenberg, Mitchell
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-30
- Volume
- 8
- Issue
- 10
- Pages
- e77992
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3813523
- OpenAlex
- W2019871490
- Cited by
- 55
- References
- 32
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 3
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (5r01ai050265-13, PO1 DK46763, DK46763)
- National Institute of Allergy and Infectious Diseases (R01AI048073, R01AI061516, AI050265, R01-AI050265, R01AI067890, AI048073, R37AI033068, AI064584, R56AI050265, R01AI064584, AI067890)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763)
- National Center for Research Resources (S10RR027366)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- BTLA, HVEM, CD8+ T cells, T cell survival, memory T cells, Listeria monocytogenes, oral bacterial infections, T cell activation, inhibitory signaling, TNF receptor superfamily
- MeSH terms
- Animals, Cells, Cultured, Flow Cytometry, Fluorescent Antibody Technique, Listeria monocytogenes, Mice, Inbred C57BL, Protein Binding, Receptors, Immunologic, CD8-Positive T-Lymphocytes, Mice, Receptors, Tumor Necrosis Factor, Member 14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.